Antibiotics for the Treatment of Patients with Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacterial Infections. [PDF]
Falagas ME +3 more
europepmc +1 more source
Biochemical and structural analyses of metallo-β-lactamase VIM-28: impact of substitutions at residues 224 and 228 on substrate profile, stability, and zinc affinity. [PDF]
Sato H +8 more
europepmc +1 more source
Perspectives on Metallo-β-Lactamase Inhibitors: Challenges and Implications of Metallo-β-Lactamase Variants. [PDF]
Lee JH, Kim DW, Lee SH.
europepmc +1 more source
The Brief Case: Pneumonia in a <i>Boa constrictor occidentalis</i> with inclusion body disease caused by multidrug-resistant VIM-type metallo-β-lactamase producing <i>Pseudomonas aeruginosa</i>. [PDF]
Broering Ferreira A +8 more
europepmc +1 more source
Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-β-lactamase-producing Enterobacterales. [PDF]
Castanheira M +4 more
europepmc +1 more source
Carbapenem resistance and antibacterial potential of the Libyan endemic plant Arbutus pavarii against metallo-β-lactamase-producing Gram-negative bacteria. [PDF]
Alwashaish MM +3 more
europepmc +1 more source
APC24-7, a covalent combination of boronic acid and chelator moieties, restores β-lactam efficiency against metallo-β-lactamase-producers. [PDF]
Hovd RR +8 more
europepmc +1 more source
Harder than Metal: Challenging Antimicrobial Resistance with Metallo-β-lactamase Inhibitors. [PDF]
De Falco A +4 more
europepmc +1 more source

